Prudent Corporate Advisory Services Ltd
Incorporated in 2003, Prudent Corporate Advisory Services Limited provides retail wealth management services. The company offers Mutual Fund products, Life and General Insurance solutions, Stock Broking services, SIP with Insurance, Gold Accumulation Plan, Asset Allocation, and Trading platforms.[1]
- Market Cap ₹ 7,983 Cr.
- Current Price ₹ 1,928
- High / Low ₹ 3,741 / 1,129
- Stock P/E 42.4
- Book Value ₹ 137
- Dividend Yield 0.10 %
- ROCE 43.3 %
- ROE 33.4 %
- Face Value ₹ 5.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 44.9% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 37.0%
Cons
- Stock is trading at 14.0 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Stock/ Commodity Brokers Industry: Finance & Investments
Part of Nifty Microcap 250 BSE Financial Services Nifty Total Market BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|
225 | 236 | 295 | 458 | 617 | 823 | 1,060 | |
185 | 188 | 225 | 335 | 436 | 612 | 806 | |
Operating Profit | 40 | 48 | 70 | 123 | 181 | 211 | 254 |
OPM % | 18% | 20% | 24% | 27% | 29% | 26% | 24% |
-1 | 0 | 0 | 0 | 2 | 1 | 28 | |
Interest | 3 | 3 | 2 | 3 | 2 | 2 | 2 |
Depreciation | 8 | 8 | 8 | 13 | 24 | 25 | 27 |
Profit before tax | 29 | 37 | 61 | 107 | 157 | 186 | 253 |
Tax % | 27% | 26% | 25% | 25% | 26% | 25% | |
21 | 28 | 45 | 80 | 117 | 139 | 188 | |
EPS in Rs | 203.37 | 269.45 | 438.27 | 19.40 | 28.18 | 33.51 | 45.51 |
Dividend Payout % | 22% | 1% | 1% | 5% | 5% | 6% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 30% |
3 Years: | 41% |
TTM: | 43% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 45% |
3 Years: | 45% |
TTM: | 39% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 38% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 36% |
3 Years: | 37% |
Last Year: | 33% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 1 | 1 | 1 | 21 | 21 | 21 | 21 |
Reserves | 82 | 111 | 157 | 217 | 329 | 461 | 547 |
30 | 17 | 13 | 13 | 17 | 20 | 27 | |
80 | 66 | 115 | 148 | 152 | 255 | 226 | |
Total Liabilities | 193 | 196 | 285 | 399 | 519 | 757 | 821 |
24 | 27 | 26 | 174 | 164 | 153 | 161 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 7 | 6 | 21 | 39 | 143 | 246 | 278 |
162 | 162 | 238 | 185 | 212 | 357 | 381 | |
Total Assets | 193 | 196 | 285 | 399 | 519 | 757 | 821 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
13 | 50 | 58 | 93 | 120 | 150 | |
13 | -2 | -28 | -163 | -106 | -139 | |
-9 | -22 | -11 | -10 | -12 | -14 | |
Net Cash Flow | 16 | 26 | 19 | -81 | 3 | -4 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Debtor Days | 126 | 61 | 85 | 75 | 61 | 63 |
Inventory Days | ||||||
Days Payable | ||||||
Cash Conversion Cycle | 126 | 61 | 85 | 75 | 61 | 63 |
Working Capital Days | 26 | -8 | -25 | -16 | -3 | -10 |
ROCE % | 33% | 41% | 52% | 51% | 43% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
8 Feb - Schedule of analyst/investor meeting on February 17, 2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
8 Feb - For schedule of Analyst/Investor Meeting to be held on 14th February,2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
8 Feb - For schedule of Analyst/Investor Meeting to be held on 13th February,2025.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
31 Jan - Transcript of the Conference call for unaudited financial results for the quarter ended 31st December, 2024.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Jan
Annual reports
Concalls
-
Jan 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Jul 2023Transcript PPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022TranscriptPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
Product Offerings[1]
A) Mutual Funds: Open-source distribution of mutual fund products.
B) Insurance: Includes life insurance (term, par, non-par, annuity plans) and general insurance (primarily health insurance).
C) Stockbroking: Services for retail customers to trade equities, derivatives, and currency.
D) Other Financial Products: PMS, AIF, P2P products, bonds, fixed deposits, smallcase, unlisted securities, LAS (Loan Against Securities), and sovereign gold bonds.